Home › Agammaglobulinemia › New Jersey
Agammaglobulinemia clinical trials in New Jersey
3 studies for Agammaglobulinemia are looking for participants at sites in New Jersey.
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Hackensack Meridian Health, Hackensack
- Carol G Simon Cancer Center, Morristown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07648264Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06976476IVIG vs SCIG in CIDP
- Rutgers, The State University of New Jersey Clinical Research Center, New Brunswick
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Dec 11, 2025 · NCT05584631From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.